{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:28:17Z","timestamp":1795080497065,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018554","name":"Science and Technology Program of Gansu Province","doi-asserted-by":"publisher","award":["25JRRA318"],"award-info":[{"award-number":["25JRRA318"]}],"id":[{"id":"10.13039\/501100018554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Androgen deprivation therapy (ADT) is essential for treating prostate cancer (PCa) but is limited by tumor heterogeneity. This study develops a non-invasive multiparametric Magnetic Resonance Imaging (mpMRI) radiomics framework to predict ADT response and improve risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      A cohort of 550 ADT-treated PCa patients from three centers was analyzed. Patients were randomly divided into training (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009270) and internal validation (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009115) cohorts. An external test cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009165) from Centers 2 and 3 was used for generalizability. Radiomics models based on T2-weighted and diffusion-weighted imaging (DWI), habitat radiomics, and a 3D Vision Transformer (ViT) deep learning model were developed. Ensemble integration of these models was performed, with SHapley Additive exPlanations (SHAP) used for interpretability. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and area under the curve (AUC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Habitat radiomics outperformed conventional radiomics in Gleason score stratification. For predicting ADT treatment efficacy,\u00a0the radiomics model achieved AUCs of 0.969 (training), 0.767 (internal validation), and 0.771 (test). The habitat model showed AUCs of 0.987, 0.849, and 0.820, while the ViT model achieved AUCs of 0.831, 0.805, and 0.796. The ensemble model reached the highest AUC of 0.886. SHAP analysis shows that the ViT model contributes most to the combined model, followed by the habitat model, with the radiomics model contributing the least.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>mpMRI-based habitat radiomics enables precise risk stratification in PCa. Integrated with conventional radiomics and deep learning, it forms a robust framework for predicting ADT response and guiding personalized treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>This study demonstrates that integrating habitat radiomics with deep learning improves the prediction of androgen deprivation therapy response in PCa, advancing personalized radiological decision-making through interpretable multi-model analysis of tumor microenvironment heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Multi-model integration of habitat radiomics and 3D Vision Transformer achieves superior prediction for ADT response compared to conventional methods.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Habitat radiomics outperforms traditional radiomics in Gleason score stratification.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>SHAP analysis provides clinical interpretability, identifying key model linked to ADT outcomes for actionable insights.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02205-8","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:34:49Z","timestamp":1769430889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Integrating deep learning with multimodal MRI habitat radiomics: toward personalized prediction of risk stratification and androgen deprivation therapy outcomes in prostate cancer"],"prefix":"10.1186","volume":"17","author":[{"given":"Yun-Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongde","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanbin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-1683","authenticated-orcid":false,"given":"Fenghai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"2205_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"2205_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.eururo.2017.06.002","volume":"73","author":"S Gillessen","year":"2018","unstructured":"Gillessen S, Attard G, Beer TM et al (2018) Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 73:178\u2013211","journal-title":"Eur Urol"},{"key":"2205_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","volume":"199","author":"MG Sanda","year":"2018","unstructured":"Sanda MG, Cadeddu JA, Kirkby E et al (2018) Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: Risk stratification, shared decision making, and care options. J Urol 199:683\u2013690","journal-title":"J Urol"},{"key":"2205_CR4","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N et al (2023) Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 21:1067\u20131096","journal-title":"J Natl Compr Canc Netw"},{"key":"2205_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","volume":"373","author":"CJ Sweeney","year":"2015","unstructured":"Sweeney CJ, Chen YH, Carducci M et al (2015) Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med 373:737\u2013746","journal-title":"N Engl J Med"},{"key":"2205_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501:346\u2013354","journal-title":"Nature"},{"key":"2205_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541\u2013550","journal-title":"Nat Med"},{"key":"2205_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41576-022-00515-3","volume":"23","author":"JR Moffitt","year":"2022","unstructured":"Moffitt JR, Lundberg E, Heyn H (2022) The emerging landscape of spatial profiling technologies. Nat Rev Genet 23:741\u2013759","journal-title":"Nat Rev Genet"},{"key":"2205_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04437-4","volume":"21","author":"W Kang","year":"2023","unstructured":"Kang W, Qiu X, Luo Y et al (2023) Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis. J Transl Med 21:598","journal-title":"J Transl Med"},{"key":"2205_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03893-7","volume":"23","author":"C Jiang","year":"2025","unstructured":"Jiang C, Qian C, Jiang Q et al (2025) Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET\/CT. BMC Med 23:49","journal-title":"BMC Med"},{"key":"2205_CR11","doi-asserted-by":"publisher","first-page":"e232047","DOI":"10.1148\/radiol.232047","volume":"309","author":"X Zhang","year":"2023","unstructured":"Zhang X, Su GH, Chen Y, Gu YJ, You C (2023) Decoding intratumoral heterogeneity: clinical potential of habitat imaging based on radiomics. Radiology 309:e232047","journal-title":"Radiology"},{"key":"2205_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01921-7","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen H, Liu Y, Zhao J et al (2024) Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: a multicenter study. Breast Cancer Res 26:160","journal-title":"Breast Cancer Res"},{"key":"2205_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1109\/TPAMI.2022.3152247","volume":"45","author":"K Han","year":"2023","unstructured":"Han K, Wang Y, Chen H et al (2023) A survey on vision transformer. IEEE Trans Pattern Anal Mach Intell 45:87\u2013110","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"2205_CR14","doi-asserted-by":"publisher","first-page":"e011149","DOI":"10.1136\/jitc-2024-011149","volume":"13","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Luo T, Yan M et al (2025) Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy. J Immunother Cancer 13:e011149","journal-title":"J Immunother Cancer"},{"key":"2205_CR15","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","volume":"44","author":"GJLH van Leenders","year":"2020","unstructured":"van Leenders GJLH, van der Kwast TH, Grignon DJ et al (2020) The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma. Am J Surg Pathol 44:e87\u2013e99","journal-title":"Am J Surg Pathol"},{"key":"2205_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.eururo.2018.06.018","volume":"74","author":"A Nabid","year":"2018","unstructured":"Nabid A, Carrier N, Martin AG et al (2018) Duration of androgen deprivation therapy in high-risk prostate cancer: a randomized phase III trial. Eur Urol 74:432\u2013441","journal-title":"Eur Urol"},{"key":"2205_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","volume":"67","author":"PL Nguyen","year":"2015","unstructured":"Nguyen PL, Alibhai SM, Basaria S et al (2015) Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67:825\u2013836","journal-title":"Eur Urol"},{"key":"2205_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2018.08.009","volume":"53","author":"V da Silva-Diz","year":"2018","unstructured":"da Silva-Diz V, Lorenzo-Sanz L, Bernat-Peguera A, Lopez-Cerda M, Mu\u00f1oz P (2018) Cancer cell plasticity: impact on tumor progression and therapy response. Semin Cancer Biol 53:48\u201358","journal-title":"Semin Cancer Biol"},{"key":"2205_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0600-4","volume":"16","author":"PR Prasetyanti","year":"2017","unstructured":"Prasetyanti PR, Medema JP (2017) Intra-tumor heterogeneity from a cancer stem cell perspective. Mol Cancer 16:41","journal-title":"Mol Cancer"},{"key":"2205_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01516-0","volume":"24","author":"X Wang","year":"2022","unstructured":"Wang X, Xie T, Luo J, Zhou Z, Yu X, Guo X (2022) Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res 24:20","journal-title":"Breast Cancer Res"},{"key":"2205_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101146","volume":"4","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhou K, Sun Z et al (2023) Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics. Cell Rep Med 4:101146","journal-title":"Cell Rep Med"},{"key":"2205_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1631\/jzus.B2200619","volume":"24","author":"X Zhu","year":"2023","unstructured":"Zhu X, Shao L, Liu Z et al (2023) MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer. J Zhejiang Univ Sci B 24:663\u2013681","journal-title":"J Zhejiang Univ Sci B"},{"key":"2205_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-06057-y","volume":"23","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang W, Liang X et al (2025) Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy. J Transl Med 23:393","journal-title":"J Transl Med"},{"key":"2205_CR24","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1016\/j.acra.2025.05.059","volume":"32","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zheng B, Zou B et al (2025) MRI radiomics and automated habitat analysis enhance machine learning prediction of bone metastasis and high-grade Gleason scores in prostate cancer. Acad Radiol 32:5303\u20135316","journal-title":"Acad Radiol"},{"key":"2205_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102260","volume":"52","author":"K Chen","year":"2025","unstructured":"Chen K, Sui C, Wang Z, Liu Z, Qi L, Li X (2025) Habitat radiomics based on CT images to predict survival and immune status in hepatocellular carcinoma, a multi-cohort validation study. Transl Oncol 52:102260","journal-title":"Transl Oncol"},{"key":"2205_CR26","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3390\/cancers14081858","volume":"14","author":"HH Cho","year":"2022","unstructured":"Cho HH, Kim H, Nam SY et al (2022) Measurement of perfusion heterogeneity within tumor habitats on magnetic resonance imaging and its association with prognosis in breast cancer patients. Cancers (Basel) 14:1858","journal-title":"Cancers"},{"key":"2205_CR27","doi-asserted-by":"publisher","first-page":"110423","DOI":"10.1016\/j.ejrad.2022.110423","volume":"154","author":"Y Yang","year":"2022","unstructured":"Yang Y, Han Y, Zhao S et al (2022) Spatial heterogeneity of edema region uncovers survival-relevant habitat of glioblastoma. Eur J Radiol 154:110423","journal-title":"Eur J Radiol"},{"key":"2205_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00884-y","volume":"9","author":"W Niu","year":"2025","unstructured":"Niu W, Yan J, Hao M et al (2025) MRI transformer deep learning and radiomics for predicting IDH wild type TERT promoter mutant gliomas. NPJ Precis Oncol 9:89","journal-title":"NPJ Precis Oncol"},{"key":"2205_CR29","doi-asserted-by":"publisher","first-page":"e222223","DOI":"10.1148\/radiol.222223","volume":"307","author":"X Jiang","year":"2023","unstructured":"Jiang X, Zhao H, Saldanha OL et al (2023) An MRI deep learning model predicts outcome in rectal cancer. Radiology 307:e222223","journal-title":"Radiology"},{"key":"2205_CR30","doi-asserted-by":"crossref","unstructured":"Chaurasia AK, Harris HC, Toohey PW, Hewitt AW (2025) A generalised vision transformer-based self-supervised model for diagnosing and grading prostate cancer using histological images. Prostate Cancer Prostatic Dis 28:918\u2013926","DOI":"10.1038\/s41391-025-00957-w"},{"key":"2205_CR31","doi-asserted-by":"publisher","first-page":"117210","DOI":"10.1016\/j.ecoenv.2024.117210","volume":"286","author":"Q Fu","year":"2024","unstructured":"Fu Q, Wu Y, Zhu M et al (2024) Identifying cardiovascular disease risk in the U.S. population using environmental volatile organic compounds exposure: a machine learning predictive model based on the SHAP methodology. Ecotoxicol Environ Saf 286:117210","journal-title":"Ecotoxicol Environ Saf"},{"key":"2205_CR32","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1007\/s00330-022-08887-0","volume":"32","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lang J, Zuo JZ et al (2022) The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. Eur Radiol 32:8737\u20138747","journal-title":"Eur Radiol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02205-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02205-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02205-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T12:34:52Z","timestamp":1769430892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02205-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02205-8","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Gansu Provincial Hospital (2023-355).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}